CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-22 | King Gary A. Exec. VP International Ops | Exercise or conversion | +30,000 | $19.47 | $584K | 151,968 |
| 2018-01-22 | King Gary A. Exec. VP International Ops | Sale | −30,000 | $39.77 | $1.2M | 121,968 |
| 2018-01-22 | King Gary A. Exec. VP International Ops | Exercise or conversion | +4,445 | $18.00 | $80K | 126,413 |
| 2018-01-22 | King Gary A. Exec. VP International Ops | Sale | −4,445 | $39.03 | $173K | 121,968 |
| 2018-01-22 | King Gary A. Exec. VP International Ops | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,445 | 0 | ||
| 2018-01-22 | King Gary A. Exec. VP International Ops | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −30,000 | 27,432 | ||
| 2018-01-22 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion | +37,654 | $30.12 | $1.1M | 157,648 |
| 2018-01-22 | MARSH RICHARD M E.V.P., General Counsel | Sale | −37,654 | $40.25 | $1.5M | 119,994 |
| 2018-01-22 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion | +3,775 | $26.49 | $100K | 123,769 |
| 2018-01-22 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion · Incentive Stock Option (right to buy) | −3,775 | 0 | ||
| 2018-01-22 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −37,654 | 0 | ||
| 2018-01-18 | King Gary A. Exec. VP International Ops | Exercise or conversion | +3,120 | $14.88 | $46K | 125,088 |
| 2018-01-18 | King Gary A. Exec. VP International Ops | Sale | −3,120 | $38.12 | $119K | 121,968 |
| 2018-01-18 | King Gary A. Exec. VP International Ops | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −3,120 | 0 | ||
| 2018-01-18 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion | +40,000 | $30.12 | $1.2M | 159,994 |
| 2018-01-18 | MARSH RICHARD M E.V.P., General Counsel | Sale | −40,000 | $38.25 | $1.5M | 119,994 |
| 2018-01-18 | MARSH RICHARD M E.V.P., General Counsel | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −40,000 | 37,654 | ||
| 2018-01-12 | MARSH RICHARD M E.V.P., General Counsel | Sale | −13,759 | $36.25 | $499K | 119,994 |
| 2018-01-05 | MARSH RICHARD M E.V.P., General Counsel | Gift | −3,000 | 133,753 | ||
| 2018-01-02 | Tobin Bernard President Crescendo BioScience | Returned to the company | −3,621 | $34.91 | $126K | 142,551 |
Page 44 of 60 · 1,194 trades